Sanofi Tumbles After Board Shockingly Ousts CEO Paul Hudson

Sanofi Stock Takes A Header After Board Shockingly Ousts CEO Paul Hudson | Investor's Business DailyBREAKING: [Stocks Pop As Goldman, Zebra, Equinix Rally]---Sanofi (SNY) stock skidded Thursday after the pharma giant's board ousted Paul Hudson as chief executive, replacing him with Merck KGaA's Belen Garijo. The news comes two weeks after the French company beat Wall Street's fourth-quarter earnings calls, but reported lighter-than-expected sales. Sanofi is best-known for Dupixent, the blockbuster drug it d ...